Goldman Sachs analyst Alexander Blostein raised the firm’s price target on Invesco (IVZ) to $30 from $27 and keeps a Neutral rating on the shares. The firm remains encouraged by the stronger organic fee growth profile, the margin expansion trajectory through 2026, and an improving balance sheet flexibility, though competition and economics could remain a relative near-term risk, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVZ: